Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Dermal Exposure to Heavy Metals in Urban Green Space Soils: A Review of Bioavailability, Toxic Mechanisms, and Precision Risk Assessment. | Toxics | 2026 | 41893504 | PubTator, text mining | PubMed |
| Multifaceted Role of Copper Homeostasis in Gut Health: From Molecular Mechanisms to Therapeutic Interventions. | Cells | 2026 | 41892335 | PubTator, text mining | PubMed |
| LDHA protects vascular endothelial cells from oxidative stress‑induced mitochondrial damage via HIF‑1α activation and glycolytic reprogramming. | Mol Med Rep | 2026 | 41891951 | PubTator, text mining | PubMed |
| Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. | Proc Natl Acad Sci U S A | 2026 | 41886374 | PubTator, text mining | PubMed |
| Cuproptosis in spinal cord injury: emerging mechanisms and immunological relevance. | Ann Med | 2026 | 41883033 | PubTator, text mining | PubMed |
| Inflammation: The Pathological Axis of Cisplatin-Induced Renal Injury. | J Inflamm Res | 2026 | 41877823 | PubTator, text mining | PubMed |
| Trace Elements and Viral Infectious Diseases: Dual Roles in Pathogenesis and Immunity. | Infect Dis Rep | 2026 | 41874145 | PubTator, text mining | PubMed |
| Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. | Ann Med | 2026 | 41869709 | PubTator, text mining | PubMed |
| Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11. | Redox Biol | 2026 | 41864191 | PubTator, text mining | PubMed |
| SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma. | Cell Death Discov | 2026 | 41856985 | PubTator, text mining | PubMed |
| The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights. | Cancer Biol Ther | 2026 | 41837409 | PubTator, text mining | PubMed |
| Transdermal siRNA delivery via biomineralized nanoparticle-incorporated microneedles modulates cuproptosis-ferroptosis interaction for psoriasis therapy. | Mater Today Bio | 2026 | 41809386 | PubTator, text mining | PubMed |
| XN@CuO/HA nanobipyramids trigger FOXO1-GADD45G-mediated cuproptosis and synergy with anti-PD-1 for lung cancer therapy. | Mater Today Bio | 2026 | 41809377 | PubTator, text mining | PubMed |
| SLC31A1 knockdown mitigates post-MI heart failure via regulation of copper metabolism. | Front Immunol | 2026 | 41808820 | PubTator, text mining | PubMed |
| Clinical Significance of Copper Chaperone for Superoxide Dismutase in Colorectal Cancer. | Ann Gastroenterol Surg | 2026 | 41799592 | PubTator, text mining | PubMed |
| Tannic Acid Achieves Rapid Scar-Free Corneal Healing by Chelating Excess Copper to Suppress Aberrant LOX-Mediated Fibrosis. | Invest Ophthalmol Vis Sci | 2026 | 41789844 | PubTator, text mining | PubMed |
| Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity. | Int J Oncol | 2026 | 41789585 | PubTator, text mining | PubMed |
| Precision Diagnosis of Wilson Disease Using a MultiGene Panel: Insights From a Prospective Cohort Study. | Neurol Genet | 2026 | 41788301 | PubTator, text mining | PubMed |
| Copper Homeostasis and Cuproptosis in Neurological Disorders. | Drug Des Devel Ther | 2026 | 41783572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=3